Is the price fair?
What ICUI's price assumes
ICU Medical, Inc. trades at 86.5× earnings against 40.2× for the median Medical Instruments & Supplies name, more expensive than its own group.
86.5
Trailing P/E · Medical Instruments & Supplies median 40.2 · 2.15× the median: the market pays up for this one
- Price / sales
- 1.51
Price / sales · as of 2026-Q1
- Free cash flow yield
- 2.2%
Free cash flow yield · Medical Instruments & Supplies median 3.7%
- Growth the price implies
- +16%
Growth the price implies · The price pays for +16% free cash flow growth a year for a decade; revenue has grown −2.2% a year over the last three.
Details›
- Price / book2026-Q1
- 1.54
- EV / EBIToperating margin 2.0%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 1.96
- Healthcare median P/E362 names
- 29.9
- Medical Instruments & Supplies median P/E29 names
- 40.2
- Free cash flow, trailing twelve months
- $83M
- Market capitalisation
- $3.72B
- 3-year revenue growth
- −2.2%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $86.89 |
| Its own P/E history, median | $92.66 |
| Its own P/E history, upper quartile | $129.88 |
| 52-week range | $114.13 – $187.34 |
| Today | $160.85 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #17 of 19 by Smart Score